Asthma and Respiratory Foundation NZ
Menu
Donate
Asthma and Respiratory Foundation NZ
In this section
Filter by topic:
All Asthma COPD Research Bronchiectasis Lung cancer Obstructive sleep apnoea Housing Smoking Management plans Other conditions Access to primary care Health literacy Poverty Health workforce Social determinants IPF Vaping COVID-19

Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus–diphtheria–acellular pertussis vaccine: a randomised, double-blind, phase 2b trial:

Cheryl Keech, MD Vicki E Miller, MD Barbara Rizzardi, MD Christopher Hoyle, MBA Melinda J Pryor, PhD Jonathan Ferrand, PhD et al.

11 March, 2023

NZ Respiratory Research Review Issue 208

Early childhood lower respiratory tract infection and premature adult death from respiratory disease in Great Britain: a national birth cohort study:

James Peter Allinson, Nishi Chaturvedi, Andrew Wong, Imran Shah, Gavin Christopher Donaldson, Jadwiga Anna Wedzicha, Rebecca Hardy

7 March, 2023

NZ Respiratory Research Review Issue 208

Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults:

Alberto Papi, M.D., Michael G. Ison, M.D., Joanne M. Langley, M.D., Dong-Gun Lee, M.D., Ph.D., Isabel Leroux-Roels, M.D., Ph.D., Federico Martinon-Torres, M.D., Ph.D., Tino F. Schwarz, M.D., Ph.D., Richard N. van Zyl-Smit, M.D., Ph.D., Laura Campora, M.D., Nancy Dezutter, Ph.D., Nathalie de Schrevel, Ph.D., Laurence Fissette, M.S., et al.

16 February, 2023

NZ Respiratory Research Review Issue 208

Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension:

Marc Humbert, Vallerie McLaughlin, J. Simon R. Gibbs, Mardi Gomberg-Maitland, Marius M. Hoeper, Ioana R. Preston, Rogerio Souza, Aaron B. Waxman, Hossein-Ardeschir Ghofrani, Pilar Escribano Subias, Jeremy Feldman, Gisela Meyer, David Montani, Karen M. Olsson, Solaiappan Manimaran, Janethe de Oliveira Pena, David B. Badesch

6 January, 2023

NZ Respiratory Research Review Issue 207

Anticoagulant Therapy for Cancer-Associated Thrombosis - A cost-effectiveness analysis:

Shuchi Gulati, MD, MS and Mark H. Eckman, MD, MS

27 December, 2022

NZ Respiratory Research Review Issue 207

Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2:

Anna C. Mavromanoli, Stefano Barco, Walter Ageno, Hélène Bouvaist, Marianne Brodmann, Claudio Cuccia, Francis Couturaud, Claudia Dellas, Konstantinos Dimopoulos, Daniel Duerschmied, Klaus Empen, Pompilio Faggiano, Emile Ferrari, Nazzareno Galiè, Marcello Galvani, Alexandre Ghuysen, George Giannakoulas, Menno V. Huisman, David Jiménez, Matija Kozak, Irene M. Lang, Nicolas Meneveau, Thomas Münzel, Massimiliano Palazzini, The PEITHO-2 Investigators

21 December, 2022

NZ Respiratory Research Review Issue 207

36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE:

Alexander G.G. Turpie, Alfredo E. Farjat, Sylvia Haas, Uma Maheshwari, Ajay K. Kakkar, on behalf of the GARFIELD-VTE investigators

24 November, 2022

NZ Respiratory Research Review Issue 207

Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial:

Walter Ageno, Lorenza Bertù, Eugenio Bucherini, Giuseppe Camporese, Francesco Dentali, Matteo Lotti, Gianfranco Lessiani, Roberto Parisi, Paolo Prandoni, Michelangelo Sartori, Adriana Visonà, Elisabetta Bigagli, Gualtiero Palareti, on behalf of the RIDTS study group

23 November, 2022

NZ Respiratory Research Review Issue 207

Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial:

Ingrid M Bistervels, MD, Andrea Buchmüller, MD, Hanke M G Wiegers, MD, Prof Fionnuala Ní Áinle, MD, Prof Bernard Tardy, MD, Jennifer Donnelly, MD et al.

28 October, 2022

NZ Respiratory Research Review Issue 207

Catheter-Directed Thrombolysis vs Anticoagulation in Patients With Acute Intermediate-High–risk Pulmonary Embolism - The CANARY Randomized Clinical Trial:

Parham Sadeghipour, MD; Yaser Jenab, MD; Jamal Moosavi, MD; et al

19 October, 2022

NZ Respiratory Research Review Issue 207